Active ingredientAmbenonium DichlorideCat. No. P-A106-001CAS 115-79-7Family · Pharmaceutical analytical standards
Ambenonium Dichloride
A reversible acetylcholinesterase inhibitor taken by mouth, used against the muscle weakness of myasthenia gravis; in the United States it left the market in 2010. This family brings together the active ingredient.
Did you know?It binds acetylcholinesterase with one of the highest affinities ever measured for this enzyme, yet it detaches quickly: a very potent but reversible inhibitor.
Go to the active ingredient →Active ingredientAmbenonium DichlorideCat. No. P-A106-001CAS 115-79-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.